Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets (Unaudited)

v3.24.1.1.u2
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Assets    
Cash and cash equivalents $ 9,252 $ 9,397
Accounts receivable, net 13,337 25,304
Non-trade receivable 564 961
Inventory 4,823 6,517
Prepaid expenses and other current assets 1,561 1,608
Total current assets 29,537 43,787
Property and equipment, net 102 71
Right-of-use assets 55
Contract fulfillment assets 9,611 9,232
Other assets 3,135 2,898
Total assets 42,385 56,043
Liabilities and stockholders’ equity    
Accounts payable 9,079 19,847
Accrued liabilities 11,884 12,233
Current portion of lease liability 55
Deferred revenue 12 12
Total current liabilities 20,975 32,147
Income tax payable 1,571 1,528
Total liabilities 22,546 33,675
Commitments and contingencies (Note 8)
Stockholders’ equity    
Common stock, $0.001 par value per share; 100,000,000 shares authorized: and 43,206,083 and 43,081,083 shares issued and outstanding at March 31, 2024, and December 31, 2023, respectively 43 43
Preferred stock, $0.001 par value per share, 5,000,000 shares authorized, and no shares issued and outstanding at March 31, 2024, and December 31, 2023, respectively
Additional paid-in capital 272,662 272,285
Accumulated deficit (252,866) (249,960)
Total stockholders’ equity 19,839 22,368
Total liabilities and stockholders’ equity $ 42,385 $ 56,043